The 2008 Frost & Sullivan Best Practices Awards has been presented to ZMC-USA representing the North American Coenzyme Q10 Emerging Company of the Year Award. ZMC-USA gained a prominent position in the marketplace within two years of its founding by strategically focusing on eliminating market restraints, such as high product prices and unnecessarily complex global value chains.
“ZMC-USA strategically altered the landscape of the marketplace and brought quality, affordability and value to a market which had suffered extreme pressures in the years prior to the company’s formation,” notes Frost & Sullivan Food Products Technical Researcher Linda Gomez. “By changing the typical market distribution channel to include transparency, ZMC-USA allowed both the customer and the parent manufacturing company to more efficiently realize the needs and demands of the US marketplace.”
ZMC-USA, LLC has been an evolution of ideals, merging two cultures together to maximize the strengths of both. ZMC-USA began March 31, 2006 as a subsidiary of its parent company, Zhejiang Medicine Company Limited Xinchang Pharmaceutical Factory (ZMC). The purpose of the company was to provide ZMC a direct conduit to the North American nutritional and pharmaceutical market. The greater purpose of ZMC-USA was to provide trust and transparency to ZMC’s customers, thereby reinforcing the long term commitments to the marketplace.
Additionally, it became this organization’s mission to provide direct correspondence and communication from the marketplace to ZMC.
“Frost & Sullivan is recognized as the premier industry analyst organization. The prestige of this award provides a continued reinforcement of both our business model and direction,” stated Scott Steinford, President, ZMC-USA. “While the support we have received from our customers during our formation since 2006 is considered our highest accolade, the recognition from Frost and Sullivan is very much appreciated.”
“The Frost and Sullivan recognition further demonstrates the commitment ZMC is making to the industry through its transparent business model, superior service and proven quality of products,” noted Sander Krupski, National Sales Manager, ZMC-USA. “This acknowledgement, when combined with other third-party endorsements, such as USP Ingredient Verification, Nutrition Business Journal and others, clearly indicates our customers are receiving the superior benefits ZMC-USA is dedicated to providing.”
Loren Israelsen, Founder of United Natural Products Alliance, reinforced the importance of the Frost and Sullivan Best Practices Award by stating, “The relevance of the ZMC-USA business model noted by Frost and Sullivan is gaining increased importance, as both legislation and customer expectations dictate the necessity of quality control and transparent verification of process. From its beginning, ZMC-USA has remained committed to the advancement of the industry, and has proven to be a valuable asset to our membership.”
About: ZMC is a multicultural raw ingredient manufacturer offering high quality leading edge pharmaceutical and nutraceutical ingredients worldwide since 1954. ZMC is staffed with over 2,000 employees worldwide and is an important production base of microbiological drugs, Coenzyme Q10, Biotin, Vitamins A and E, Lutein, Phytosterol, B-Carotene, and Lycopene.